Hypersensitivity and allergy
New drug could reduce symptoms of gluten exposure in people with coeliac disease
Research into a drug to reduce symptoms of inadvertent gluten exposure in people with coeliac disease has shown promising results.
Source: Biophoto Associates / Science Photo Library
A monoclonal antibody could help reduce symptoms of coeliac disease in people with the condition who are accidentally exposed to gluten, according to study findings presented at Digestive Disease Week, held in Washington DC on 2–5 June 2018.
Researchers randomly assigned patients on a gluten-free diet to six injections of the drug, known as AMG 714, at a dose of either 150mg or 300mg, or a placebo over a ten-week period. From week 2 to 2 weeks after treatment (week 12), the patients then underwent a gluten exposure challenge.
While there was no significant difference in the primary end point — a measurement of damage to the villous lining of the intestine — between treatment groups, there were significant reductions in inflammation and symptoms in response to gluten consumption.
Patients receiving the highest dose of AMG 714 had no clinically active disease at week 12 and also had a significant improvement in self-reported outcomes, compared with placebo.
The researchers said there was a need for treatments for coeliac disease, as even on a gluten-free diet people are often inadvertently exposed to gluten.
“AMG 714 merits development as an adjunct to [gluten-free diet] in non-responsive coeliac disease,” they concluded.
Citation: Clinical Pharmacist DOI: 10.1211/CP.2018.20205174
Recommended from Pharmaceutical Press
This new edition of Dale and Appelbe's Pharmacy and Medicines Law is the definitive guide to law and ethics for pharmacy practice in the UK. It covers law and professional regulation and is firmly established as the definitive student textbook and reference work on this subject in the UK. Fully updated to include changes to pharmacy laws and regulation.£57.00Buy now
Pharmacy Registration Assessment Questions 2 features more than 400 entirely new, closed book and calculation questions. It can be used in conjunction with the previous volume or on its own. All questions are in line with current GPhC guidance, enabling you to prepare for the pharmaceutical pre-registration exam with confidence.£35.00Buy now
Pharmacy Registration Assessment Questions 3 is the third volume in a series that follows on from the previous, highly popular Pharmacy Registration Assessment Questions 2. It features more than 400 entirely new, closed book and calculation questions. It can be used in conjunction with the previous volume or on its own.£35.00Buy now
Pharmacy Registration Assessment Questions features over 400 closed book and calculation questions. With the registration exam having gone through a complete transformation in 2016, this volume has been developed around the new General Pharmaceutical Council (GPhC) guidelines.£33.00Buy now